Truepill Revenue and Competitors

Location

$255.4M

Total Funding

Estimated Revenue & Valuation

  • Truepill's estimated annual revenue is currently $90.3M per year.(i)
  • Truepill's estimated revenue per employee is $177,800
  • Truepill's total funding is $255.4M.
  • Truepill's current valuation is $1.6B.

Employee Data

  • Truepill has 508 Employees.(i)
  • Truepill grew their employee count by -2% last year.

Truepill's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Head PharmacyReveal Email/Phone
4
Head Customer Success and GrowthReveal Email/Phone
5
Head DataReveal Email/Phone
6
SVP EngineeringReveal Email/Phone
7
Head Talent Acquisition & Head Human ResourcesReveal Email/Phone
8
Head CommunicationsReveal Email/Phone
9
VP, Client Strategy ExecutiveReveal Email/Phone
10
SVP, Platform SolutionsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$167.4M836-20%$65K$1B
#2
$185M924-1%$93.9MN/A
Add Company

What Is Truepill?

Truepill is the software-powered pharmacy of the future serving healthcare brands worldwide.

keywords:saas

$255.4M

Total Funding

508

Number of Employees

$90.3M

Revenue (est)

-2%

Employee Growth %

$1.6B

Valuation

N/A

Accelerator

Truepill News

2022-04-20 - Truepill Appoints John Foster as Chief People Officer

SAN MATEO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Truepill, the digital health platform connecting telehealth, diagnostics, and pharmacy...

2022-04-06 - Mental health startup Ahead is shutting down

Flashback: Founded in 2019, Ahead raised $9 million from digital pharmacy enabler Truepill. Details: Ahead will no longer accept new patients,...

2022-03-30 - COVID-19 Testing Leader Curative Announces Partnership ...

Truepill powers the future of consumer healthcare, connecting telehealth, diagnostic, and pharmacy infrastructure to create innovative solutions...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$94.4M521-3%N/A
#2
$151.2M53343%N/A
#3
$94.8M5330%$237.2M
#4
$97M5356%N/A
#5
$54.6M537-1%$269M